⌘K

Login Start Free

FENNEC PHARMACEUTICALS INC.·4

Apr 16, 6:00 PM ET

Haigh Adrian 4

4 · FENNEC PHARMACEUTICALS INC. · Filed Apr 16, 2024

Insider Transaction Report

Form 4

Period: 2024-04-15

FENNEC PHARMACEUTICALS INC.FENC

Director

Transactions

Exercise/Conversion
Common Shares
2024-04-16$2.31/sh−22,222$51,333→ 449,135 total
Exercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Options (22,222 underlying)
Sale
Common Shares
2024-04-16$2.31/sh+22,222$51,333→ 44,444 total
Sale
Common Shares
2024-04-15$2.31/sh+22,222$51,333→ 22,222 total
Sale
Common Shares
2024-04-16$10.28/sh−22,222$228,389→ 0 total
Sale
Common Shares
2024-04-15$10.30/sh−22,222$228,793→ 22,222 total
Exercise/Conversion
Common Shares
2024-04-15$2.31/sh−22,222$51,333→ 471,357 total
Exercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Options (22,222 underlying)

Footnotes (6)

[F1]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
[F2]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
[F3]Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
[F4]Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.
[F5]Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
[F6]Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.

Documents

1 file

4
form4-04162024_100446.xmlPrimary